Fa'ato'a taunu'u 4-Biphenylcarboxylic Acid (92-92-2)

Faatasi ai ma la matou pulega mataʻina, tomai faʻatekinisi mamana faʻapitoa faʻataʻitaʻiga auʻu, matou te faʻaauau pea ona tuʻuina atu ia matou tagata faʻatau le tulaga lelei lelei, tau faʻatauga talafeagai ma auaunaga sili ona lelei.Matou te faʻamoemoe e avea ma se tasi o au paaga sili ona faʻamoemoeina ma maua lou faʻamalieina mo le Newly Arrival 4-Biphenylcarboxylic Acid (92-92-2), O le mataupu faavae o la matou faʻapotopotoga o taimi uma e tuʻuina atu ai oloa maualuga, auaunaga faʻapitoa, ma fesoʻotaʻiga faamaoni. .Fa'afeiloa'i uo uma e tu'u le fa'ata'ita'iga mo le faia o se faiga fa'apa'aga atina'e umi.
Faatasi ai ma la matou pulega mataʻina, tomai faʻatekinisi mamana faʻapitoa faʻataʻitaʻiga auʻu, matou te faʻaauau pea ona tuʻuina atu ia matou tagata faʻatau le tulaga lelei lelei, tau faʻatauga talafeagai ma auaunaga sili ona lelei.Matou te faʻamoemoe e avea ma se tasi o au paaga sili ona faʻamoemoeina ma maua lou faʻamalieina moSaina Organic Synthesis Intermediates, O a tatou oloa e masani ona auina atu i fafo i Asia i Sautesasae, Sasaʻe Tutotonu, Amerika i Matu ma Europa.E mautinoa e mautinoa lo matou tulaga lelei.Afai e te fiafia i soʻo se a matou oloa pe e te manaʻo e talanoa i se faʻatonuga masani, ia mautinoa e te lagona le saoloto e faʻafesoʻotaʻi i matou.O loʻo matou tulimatai atu i le fausiaina o sootaga faʻapisinisi manuia ma tagata fou i le salafa o le lalolagi i se taimi lata mai.

2'-hydroxy-3'-nitro-3-biphenylcarboxylic acid o loʻo faʻaaogaina e avea ma mea vavalalata o Eltrombopag.
Eltrombopag, atiina ae e GlaxoSmithKline (GSK) i Peretania ma mulimuli ane atiina ae soofaatasi ma Novartis i Suitiselani, o le muamua ma e naʻo le faʻatagaina laiti mole non peptide TPO receptor agonist i le lalolagi.Eltrombopag na faʻamaonia e le US FDA i le 2008 mo le togafitiga o le idiopathic thrombocytopenic purpura (ITP), ma i le 2014 mo togafitiga o le maʻi aplastic anemia (AA).O le vailaʻau muamua foʻi na faʻamaonia e le US FDA mo togafitiga o le AA i le 30 tausaga talu ai nei.
I le december2012, ua faamaonia e le US FDA Eltrombopag mo le togafitiga o thrombocytopenia i tagata mamaʻi ma hepatitis C (CHC), ina ia hepatitis C maʻi ma le le lelei prognosis ona o le maualalo platelet faitau e mafai ona amata ma tausia interferon faavae togafitiga tulaga mo maʻi ate.I le Fepuari3, 2014, GlaxoSmithKline na faʻasalalau e le FDA na tuʻuina atu le agavaa o vailaʻau faʻapitoa mo togafitiga o Eltrombopag mo togafitiga o le hemopenia i tagata mamaʻi e maua i le chemicalbook aplastic anemia (SAA) e leʻi tali atoatoa i le immunotherapy.I le aso 24 o Aokuso, 2015, na faʻamaonia ai e le US FDA Eltrombopag mo togafitiga o le thrombocytopenia i tagata matutua ma tamaiti e taʻi 1 tausaga ma sili atu ma le thrombocytopenia puipuia tumau (ITP) e le lava le tali atu i corticosteroids, immunoglobulins poʻo splenectomy.I le Ianuari 4, 2018, na faʻamaonia ai Eltrombopag e lisiina i Saina mo togafitiga o le thrombocytopenia puipuia muamua (ITP).

Faatasi ai ma la matou pulega mataʻina, tomai faʻatekinisi mamana faʻapitoa faʻataʻitaʻiga auʻu, matou te faʻaauau pea ona tuʻuina atu ia matou tagata faʻatau le tulaga lelei lelei, tau faʻatauga talafeagai ma auaunaga sili ona lelei.Matou te faʻamoemoe e avea ma se tasi o au paaga sili ona faʻamoemoeina ma maua lou faʻamalieina mo le Newly Arrival 4-Biphenylcarboxylic Acid (92-92-2), O le mataupu faavae o la matou faʻapotopotoga o taimi uma e tuʻuina atu ai oloa maualuga, auaunaga faʻapitoa, ma fesoʻotaʻiga faamaoni. .Fa'afeiloa'i uo uma e tu'u le fa'ata'ita'iga mo le faia o se faiga fa'apa'aga atina'e umi.
Fou FouSaina Organic Synthesis Intermediates, O a tatou oloa e masani ona auina atu i fafo i Asia i Sautesasae, Sasaʻe Tutotonu, Amerika i Matu ma Europa.E mautinoa e mautinoa lo matou tulaga lelei.Afai e te fiafia i soʻo se a matou oloa pe e te manaʻo e talanoa i se faʻatonuga masani, ia mautinoa e te lagona le saoloto e faʻafesoʻotaʻi i matou.O loʻo matou tulimatai atu i le fausiaina o sootaga faʻapisinisi manuia ma tagata fou i le salafa o le lalolagi i se taimi lata mai.